To further confirm the connection between MKP-1 and Nrf2, we used three independent MKP-1 siRNAs to knock down MKP-1 in both A549 and H460 NSCLC cells to minimize any off-target effects. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.